BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA)
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies.
BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA)
Industry:
Biotechnology Health Care
Founded:
2006-01-01
Address:
Washington, District Of Columbia, United States
Country:
United States
Website Url:
http://www.medicalcountermeasures.gov
Total Employee:
251+
Status:
Active
Contact:
202-260-1200
Email Addresses:
[email protected]
Technology used in webpage:
SPF
Similar Organizations
Allegheny Health Network
Allegheny Health Network is a healthcare facility specializing in primary care, neuroscience, and mental health services.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
NantWorks
NantWorks combines semiconductor technology, supercomputing and advanced networks to improve healthcare, commerce and digital entertainment.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-31 | Arcturus Therapeutics | Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Arcturus Therapeutics | 63.2 M USD |
| 2022-08-30 | Spectral MD | Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Spectral MD | 8.2 M USD |
| 2022-08-24 | Everglade Consulting | Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Everglade Consulting | 39 M USD |
| 2022-07-12 | SeLux Diagnostics | Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - SeLux Diagnostics | 8 M USD |
| 2022-05-03 | BugSeq Bioinformatics | Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - BugSeq Bioinformatics | N/A |
| 2022-03-22 | Visby Medical | Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Visby Medical | 25.5 M USD |
| 2022-03-01 | The Stevanato Group | Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - The Stevanato Group | 95 M USD |
| 2022-01-25 | Opiant Pharmaceuticals | Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Opiant Pharmaceuticals | 2 M USD |
| 2022-01-19 | Spero Therapeutics | Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Spero Therapeutics | 12.9 M USD |
| 2022-01-06 | Cue | Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Cue | N/A |
Official Site Inspections
http://www.medicalcountermeasures.gov Semrush global rank: 3.33 M Semrush visits lastest month: 4.83 K
- Host name: 20.96.166.48
- IP address: 20.96.166.48
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biomedical Advanced Research and Development Authority (BARDA)"
Who We Are - Medical Countermeasures
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS. A lock or https:// means you’ve safely connected to the .gov website. ...See details»
Medical Countermeasures and Biodefense - ASPR
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPSSee details»
Medical Countermeasures Initiative (MCMi) | FDA
May 1, 2024 MCMi, the FDA Medical Countermeasures Initiative, is an FDA-wide initiative to coordinate medical countermeasure development, preparedness, and response. Learn more …See details»
What are Medical Countermeasures? | FDA
Feb 15, 2023 Through the FDA Medical Countermeasures Initiative , FDA works with partners at all levels of government—local, state, national and international—to support MCM-related public health ...See details»
Medical Countermeasure Resources - FDA
Apr 29, 2024 Information related to medical countermeasures and public health emergency preparedness from FDA and MCMi government partners. ... (PRET) (World Health …See details»
Biomedical Advanced Research and Development …
BARDA Programs. The mission of the Biomedical Advanced Research and Development Authority (BARDA) is to develop medical countermeasures that address the public health and medical consequences of chemical, biological, …See details»
CHEMICAL, BIOLOGICAL, RADIOLOGICAL, AND …
The goal of AR&D funding is to build a sustainable MCM pipeline to prevent or treat illnesses and injuries caused by CBRN threats. AR&D funds support innovative products through all phases of the development pipeline, from …See details»
Mass Distribution and Dispensing/Administration of Medical ...
Planning considerations and response efforts for MCMs can be quite complex due to the need to address varied incident types and scale; potential tight time constraints and significant …See details»
Vaccine and Other Medical Countermeasures
Vaccine and Medical Countermeasures. Safe, effective, and readily available MCMs, including vaccines, antiviral drugs, therapeutics, diagnostics, ventilators, and respiratory protection devices, are critical to HHS's goal in preventing …See details»
About MCMi | FDA - U.S. Food and Drug Administration
Jun 5, 2023 The Medical Countermeasures Initiative (MCMi) is an FDA-wide initiative to coordinate medical countermeasure development, preparedness and response, led by the Office of Counterterrorism and ...See details»
MC2 – Medical Countermeasures Coalition
MC2 is made up by member organizations that have a shared stake in our mission to build an effective medical countermeasure enterprise, further innovation, and enhance public health …See details»
How To Help - FEMA.gov
May 11, 2023 A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS. A lock ( A locked ... please go to …See details»
Preparedness and Response—Global Regulatory Approvals for …
Jul 29, 2024 Figure: During outbreaks, medical countermeasures (MCMs) with data packages that can support approval by stringent regulatory authority (SRAs) can expedite local …See details»
(i-MCM-Net) - World Health Organization (WHO)
Sep 13, 2024 WHO interim Medical Countermeasures Network (i-MCM-Net). The initiative’s vision is to provide timely and equitable access to quality, safe, effective and affordable MCMs …See details»
MEDICAL COUNTERMEASURES Fact Sheet - Johns Hopkins Center …
And Therapy Trials Listed on ClinicalTrials.gov. Vaccines Clinical Trial Status SARS MERS. Recruiting 0 1 Active 0 0 Completed 2 0 Withdrawn or unknown status 2. 12,13. 0. Therapies …See details»
Medical Countermeasures (MCMs) - U.S. Food and Drug …
MEDICAL COUNTERMEASURES (MCMS). FDA-REGULATED MEDICAL PRODUCTS. Medical countermeasures, or MCMs, are FDA-regulated products that may be used in a . PUBLIC …See details»
Publications - Medical Countermeasures
The U.S. Government has a responsibility to protect the health and safety of its citizens. The American people continue to face a host of national health security threats from chemical, …See details»
WHO design and consultation process on a new medical …
Feb 3, 2023 The COVID-19 pandemic has reaffirmed the urgent need for a multi-disease, end-to-end medical countermeasures platform for the rapid development of, and equitable access …See details»
Newsroom - Medical Countermeasures
Nov 21, 2024 As part of the Biden-Harris Administration’s commitment to ensuring Americans who get sick with COVID-19 have access to treatments that work, today U.S. Department of …See details»